ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OFLERCANIDIPINE IN DAILY CLINICAL PRACTICE. THE ELYPSE STUDY

ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OFLERCANIDIPINE IN DAILY CLINICAL PRACTICE. THE ELYPSE STUDY

Aim: Lercanidipine, a long-acting dihydropyridine with a good antihypertensive efficacy and tolerability. The aim of the ELYPSE trial was to determine the efficacy and tolerability of this medication in daily clinical practice. Methods: Patients with Stage 1-2 essential hypertension, in whom their p...

Full description

Bibliographic Details
Main Authors:	Vivencio Barrios, Angel Navarro, Manuel Luque, Joaquima Romero, Juan Tamargo, Luis Prieto, Jose Luis Carrasco, Inmaculada Herranz, Josefa Navarro-Cid, Luis M. Ruilope, Antonio Esteras
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-08-01
Series:	Российский кардиологический журнал
Subjects:	arterial hypertension calcium-channel blocker daily clinical practice dihydropyridine lercanidipine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1471

Similar Items

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01)

STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS)
by: E. O. Taratukhin
Published: (2013-08-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
by: Vivencio Barrios, et al.
Published: (2008-08-01)

Pleiotropic features of dihydropyridine calcium channel antagonists
by: G S Anikin
Published: (2014-09-01)

Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
by: V. Barrios, et al.
Published: (1970-01-01)

Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment
by: V S Zadionchenko, et al.
Published: (2013-12-01)

Application of lercanidipine in the treatment of hypertension
by: G. G Shehyan, et al.
Published: (2014-06-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

Challenges in hypotensive therapy: the role of calcium antagonists
by: E. O. Taratukhin, et al.
Published: (2013-04-01)

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01)

RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2017-01-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

Design and synthesis of novel 4-substituted 1,4-dihydropyridine derivatives as hypotensive agents
by: Prasanna A. Datar, et al.
Published: (2016-09-01)

Calcium Channel Blocker-Associated Chyloperitoneum in Patients Receiving Peritoneal Dialysis: A Systematic Review
by: Seungyeon Kim, et al.
Published: (2019-04-01)

Blood Pressure and Metabolic Effect of a Combination of Lercanidipine with Different Antihypertensive Drugs in Clinical Practice
by: Arrigo F.G. Cicero, et al.
Published: (2012-02-01)

Synthesis of Novel 1,4- Dihydropyridine Derivatives Bearing Biphenyl-2'-Tetrazole Substitution as Potential Dual Angiotensin II Receptors and Calcium Channel Blockers
by: Javid Shahbazi Mojarrad, et al.
Published: (2011-06-01)

ASSESSMENT OF COGNITIVE FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION TREATED WITH LERCANIDIPINE
by: J. Tisaire-Sánchez, et al.
Published: (2011-04-01)

Treatment of proteinuria with lercanidipine associated with reninangiotensin axis-blocking drugs
by: N. R. Robles, et al.
Published: (2011-06-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

Case report on low dose of Cilnidipine: A fourth-generation calcium channel blocker-induced gingival overgrowth
by: Sameera Gopinath, et al.
Published: (2019-01-01)

Perioperative Acute Hypertension – Role of Clevidipine Butyrate
by: Lakshmi N Kurnutala, et al.
Published: (2014-08-01)

Left Ventricular Structure during Antihypertensive Treatment in Patients with Chronic Kidney Disease
by: Batir T. Daminov, et al.
Published: (2016-03-01)

Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1
by: Xiaohui Pan, et al.
Published: (2021-01-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
by: S. R. Gilyarevskyi, et al.
Published: (2014-04-01)

Antihypertensive effects of new dihydropyridine derivatives on phenylephrine-raised blood pressure in rats
by: Sara Rowghani Haghighi Fard, et al.
Published: (2016-01-01)

Lercanidipine in arterial hypertension
by: C. Borghi
Published: (1970-01-01)

CLINICAL EFFECTS AND RENOPROTECTIVE FACILITIES OF OLMESARTAN AND LERKANIDIPINEAS MONOTHERAPY AND WHEN COMBINED APPLICATION IN PATIENTS WITH ARTERIAL HYPERTENSION
by: A G Evdokimova, et al.
Published: (2016-03-01)

The control of blood pressure level as the prevention of cognitive impairment
by: M V Melnik, et al.
Published: (2016-12-01)

The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes
by: Botir T. Daminov, PhD, ScD, et al.
Published: (2013-06-01)

The control of blood pressure level as the prevention of cognitive impairment
by: Melnik M.V., et al.
Published: (2016-12-01)

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
by: E. I. Emelina, et al.
Published: (2015-11-01)

Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01)

Differentiated approach to the use of optimal medical therapy in patients with various clinical forms of stable ischemic heart disease
by: I. I. Shaposhnik, et al.
Published: (2019-01-01)

FIXED ANTIHYPERTENSIVE DRUGS COMBINATION SELECTION WITH THE AIM OF ORGANS PROTECTION
by: O. D. Ostroumova, et al.
Published: (2015-05-01)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

Consistence of the radial artery as a conduit used in aortocoronary bypass surgery, a possibility of preventing shunt spasm
by: T M Ripp, et al.
Published: (2012-12-01)

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
by: Antza C, et al.
Published: (2016-11-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

Cannot write session to /tmp/vufind_sessions/sess_6o01sri0j0pgq5t0e5660fas76